ALUR Stock Summary and Trading Ideas (Allurion Technologies | NYSE:ALUR)

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Allurion Technologies trades on the NYSE stock market under the symbol ALUR.

As of March 9, 2026, ALUR stock price was flat at $0.67 with million shares trading.

ALUR has a beta of 2.27, meaning it tends to be more sensitive to market movements. ALUR has a correlation of 0.13 to the broad based SPY ETF.

ALUR has a market cap of $8.24 million. This is considered a Sub-Micro Cap stock.

Last quarter Allurion Technologies reported $3 million in Revenue and -$1.18 earnings per share. This beat revenue expectation by $608,000 and exceeded earnings estimates by $.56.

The top ETF exchange traded funds that ALUR belongs to (by Net Assets): VXF.

ALUR has underperformed the market in the last year with a price return of -73.8% while the SPY ETF gained +19.7%. ALUR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -60.5% and -38.4%, respectively, while the SPY returned -0.8% and -1.6%, respectively.

ALUR support price is $.60 and resistance is $.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALUR shares will trade within this expected range on the day.